Filing Details

Accession Number:
0001127602-20-010524
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-13 09:05:05
Reporting Period:
2020-03-12
Accepted Time:
2020-03-13 09:05:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
794172 Meridian Bioscience Inc VIVO In Vitro & In Vivo Diagnostic Substances (2835) 310888197
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1719325 P. John Kenny 3471 River Hills Drive
Cincinnati OH 45244
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-03-12 30,000 $5.78 238,324 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Prices range from $5.7300 per share to $5.7900 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.